Medlive Technology (02192) Announces January 2026 Monthly Return

Bulletin Express

02/05

Medlive Technology Co., Ltd. (stock code: 02192) released its January 2026 monthly return on equity securities, which showed no changes in the authorized share capital. The total authorized/registered capital remained at USD 500,000, corresponding to 50,000,000,000 ordinary shares with a par value of USD 0.00001 each.

During January 2026, the total number of issued ordinary shares increased from 737,030,875 to 737,960,875. This rise of 930,000 shares resulted from the exercise of options under the Pre-IPO Share Option Scheme at an exercise price of RMB 0.38 per share, generating RMB 353,400 of funds.

The company confirmed that the public float requirement stands at 24.98% of the total issued shares for this class, and the requirement was satisfied as of the end of January 2026. No additional equity-related instruments, such as warrants or convertibles, were reported.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1196249974"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1196249974\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1196249974?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-05 16:59","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1196249974","market":"hk","top_or_hot":-1,"title":"Medlive Technology (02192) Announces January 2026 Monthly Return","media":"Bulletin Express","content":"<p>Medlive Technology Co., Ltd. (stock code: 02192) released its January 2026 monthly return on equity securities, which showed no changes in the authorized share capital. The total authorized/registered capital remained at USD 500,000, corresponding to 50,000,000,000 ordinary shares with a par value of USD 0.00001 each.</p>\n<p>During January 2026, the total number of issued ordinary shares increased from 737,030,875 to 737,960,875. This rise of 930,000 shares resulted from the exercise of options under the Pre-IPO Share Option Scheme at an exercise price of RMB 0.38 per share, generating RMB 353,400 of funds.</p>\n<p>The company confirmed that the public float requirement stands at 24.98% of the total issued shares for this class, and the requirement was satisfied as of the end of January 2026. No additional equity-related instruments, such as warrants or convertibles, were reported.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Medlive Technology (02192) Announces January 2026 Monthly Return</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMedlive Technology (02192) Announces January 2026 Monthly Return\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2026-02-05 16:59</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Medlive Technology Co., Ltd. (stock code: 02192) released its January 2026 monthly return on equity securities, which showed no changes in the authorized share capital. The total authorized/registered capital remained at USD 500,000, corresponding to 50,000,000,000 ordinary shares with a par value of USD 0.00001 each.</p>\n<p>During January 2026, the total number of issued ordinary shares increased from 737,030,875 to 737,960,875. This rise of 930,000 shares resulted from the exercise of options under the Pre-IPO Share Option Scheme at an exercise price of RMB 0.38 per share, generating RMB 353,400 of funds.</p>\n<p>The company confirmed that the public float requirement stands at 24.98% of the total issued shares for this class, and the requirement was satisfied as of the end of January 2026. No additional equity-related instruments, such as warrants or convertibles, were reported.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02192","symbol_name":"醫脈通","start_time":0,"source_url":"","article_id":"1196249974","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1196249974","pubTimestamp":1770281945,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Medlive Technology Co., Ltd. (stock code: 02192) released its January 2026 monthly return on equity securities, which showed no changes in the authorized share capital. The total...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02192":"医脉通"},"translate_title":"Medlive Technology(02192)公布2026年1月月报表","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02192":1},"content_text":"Medlive Technology Co., Ltd. (stock code: 02192) released its January 2026 monthly return on equity securities, which showed no changes in the authorized share capital. The total authorized/registered capital remained at USD 500,000, corresponding to 50,000,000,000 ordinary shares with a par value of USD 0.00001 each.\nDuring January 2026, the total number of issued ordinary shares increased from 737,030,875 to 737,960,875. This rise of 930,000 shares resulted from the exercise of options under the Pre-IPO Share Option Scheme at an exercise price of RMB 0.38 per share, generating RMB 353,400 of funds.\nThe company confirmed that the public float requirement stands at 24.98% of the total issued shares for this class, and the requirement was satisfied as of the end of January 2026. No additional equity-related instruments, such as warrants or convertibles, were reported.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"dataReport,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}